IRIS
BATTAGLIA, Michele
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 20.500
AS - Asia 8.742
EU - Europa 8.547
SA - Sud America 2.419
AF - Africa 303
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 11
AN - Antartide 2
Totale 40.540
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 20.196
SG - Singapore 3.737
IT - Italia 3.018
CN - Cina 1.995
BR - Brasile 1.948
HK - Hong Kong 1.150
SE - Svezia 969
DE - Germania 886
RU - Federazione Russa 770
UA - Ucraina 732
FR - Francia 655
FI - Finlandia 598
VN - Vietnam 547
GB - Regno Unito 409
IN - India 279
AR - Argentina 176
BD - Bangladesh 160
CA - Canada 152
IQ - Iraq 131
ID - Indonesia 96
BE - Belgio 95
TR - Turchia 90
ZA - Sudafrica 89
MX - Messico 84
CO - Colombia 77
IE - Irlanda 75
SA - Arabia Saudita 70
PK - Pakistan 69
NL - Olanda 66
JP - Giappone 62
VE - Venezuela 61
EC - Ecuador 60
UZ - Uzbekistan 53
PH - Filippine 52
PL - Polonia 51
ES - Italia 47
CI - Costa d'Avorio 42
MA - Marocco 38
CH - Svizzera 31
KE - Kenya 28
CL - Cile 24
IR - Iran 24
MY - Malesia 23
JO - Giordania 22
TN - Tunisia 22
PY - Paraguay 20
AZ - Azerbaigian 19
LT - Lituania 19
PE - Perù 19
AE - Emirati Arabi Uniti 18
AT - Austria 16
KR - Corea 16
UY - Uruguay 16
EG - Egitto 15
ET - Etiopia 14
AU - Australia 13
JM - Giamaica 13
LB - Libano 13
OM - Oman 13
RO - Romania 13
BO - Bolivia 12
PS - Palestinian Territory 12
CZ - Repubblica Ceca 11
NP - Nepal 11
TH - Thailandia 11
AL - Albania 10
KZ - Kazakistan 10
PT - Portogallo 10
BG - Bulgaria 9
CR - Costa Rica 9
DZ - Algeria 9
HN - Honduras 9
IL - Israele 9
DO - Repubblica Dominicana 8
EU - Europa 8
RS - Serbia 8
BH - Bahrain 7
PA - Panama 7
HU - Ungheria 6
BY - Bielorussia 5
GE - Georgia 5
HR - Croazia 5
KG - Kirghizistan 5
NI - Nicaragua 5
SN - Senegal 5
SY - Repubblica araba siriana 5
TT - Trinidad e Tobago 5
CG - Congo 4
DK - Danimarca 4
EE - Estonia 4
GR - Grecia 4
LU - Lussemburgo 4
LY - Libia 4
NG - Nigeria 4
SR - Suriname 4
TW - Taiwan 4
AM - Armenia 3
BB - Barbados 3
CY - Cipro 3
GA - Gabon 3
Totale 40.460
Salva come PNG Salva come JPEG
Città #
Singapore 2.023
Fairfield 2.021
Ashburn 1.897
Chandler 1.714
Jacksonville 1.619
Woodbridge 1.433
Hong Kong 1.143
San Jose 956
Houston 879
Seattle 859
Cambridge 767
Wilmington 708
Nyköping 659
Ann Arbor 636
Beijing 528
Roxbury 415
Lawrence 414
Nanjing 391
New York 370
Lauterbourg 363
Des Moines 277
Bari 258
Dallas 255
Los Angeles 252
Helsinki 185
Rome 183
Boardman 181
Princeton 177
São Paulo 177
Ho Chi Minh City 173
Munich 154
Milan 150
Santa Clara 148
Buffalo 115
Brooklyn 113
Council Bluffs 108
Shenyang 107
Hanoi 102
Nanchang 102
London 97
Inglewood 96
Hebei 95
San Diego 92
Brussels 89
Dearborn 74
Dong Ket 73
Jiaxing 72
Dublin 71
Naples 63
Rio de Janeiro 63
Chicago 61
Tianjin 60
Changsha 59
Frankfurt am Main 58
Paris 57
Redwood City 56
Baghdad 53
Belo Horizonte 53
Toronto 53
Pune 51
Orem 50
Tokyo 49
Tashkent 48
Montreal 47
The Dalles 47
Columbus 44
Abidjan 42
Jakarta 42
Brasília 41
Florence 40
Johannesburg 40
Moscow 40
Turku 40
Boston 39
Phoenix 37
Atlanta 36
Campinas 35
Curitiba 35
Palermo 35
Warsaw 35
Bologna 34
Nuremberg 33
Stockholm 32
Turin 31
San Francisco 30
Chennai 29
Guangzhou 29
Riyadh 28
Buenos Aires 27
Augusta 26
Falls Church 26
Porto Alegre 26
Falkenstein 25
Nairobi 25
Washington 25
Caracas 24
Mexico City 24
Bogotá 23
Denver 23
Lahore 23
Totale 25.823
Salva come PNG Salva come JPEG
Nome #
L’INFILTRAZIONE PERINEURALE E LA POSITIVITA’ DEI MARGINI CHIRURGICI NELLA PROGNOSI DEI PAZIENTI CON CARCINOMA PROSTATICO SOTTOPOSTI A PROSTATECTOMIA RADICALE. 1.608
ACCESSO LOMBOTOMICO VS ACCESSO TRANSPERITONEALE NELLA CHIRURGIA DEL CARCINOMA RENALE. RISULTATI PRELIMINARI DI UNO STUDIO RANDOMIZZATO. 656
miR-29b and miR-198 overexpression in CD8+ T cells of renal cell carcinoma patients down-modulates JAK3 and MCL-1 leading to immune dysfunction 251
Renal progenitor cells revert LPS-induced endothelial-to-mesenchymal transition by secreting CXCL6, SAA4, and BPIFA2 antiseptic peptides 225
Metabolomic profile of glycolysis and the pentose phosphate pathway identifies the central role of glucose-6-phosphate dehydrogenase in clear cell-renal cell carcinoma. 219
A 1-year maintenance after early adjuvant intravesical chemotherapy has a limited efficacy in preventing recurrence of intermediate risk non-muscle-invasive bladder cancer. 214
LE ANASTOMOSI URETERO-INTESTINALI: CONDOTTO ILEALE CON URETERO - ILEOANASTOMOSI SECONDO WALLACE. 213
Integrated multi-omics characterization reveals a distinctive metabolic signature and the role of NDUFA4L2 in promoting angiogenesis, chemoresistance, and mitochondrial dysfunction in clear cell renal cell carcinoma 206
Loss of STK11 expression is an early event in prostate carcinogenesis and predicts therapeutic response to targeted therapy against MAPK/p38. 202
Increased Expression of the Autocrine Motility Factor is Associated With Poor Prognosis in Patients With Clear Cell-Renal Cell Carcinoma 201
Activation of the kynurenine pathway predicts poor outcome in patients with clear cell renal cell carcinoma 201
Complement Modulation of Anti-Aging Factor Klotho in Ischemia/Reperfusion Injury and Delayed Graft Function 199
LA FISTOLA CAVERNO-SPONGIOSA SECONDO WINTER NEL TRATTAMENTO DEL PRIAPISMO IDIOPATICO. 194
Complement component C5a induces aberrant epigenetic modifications in renal tubular epithelial cells accelerating senescence by Wnt4/βcatenin signaling after ischemia/reperfusion injury 193
Serum sarcosine increases the accuracy of prostate cancer detection in patients with total serum PSA less than 4.0 ng/ml. 191
Addition of sirolimus to cyclosporine delays the recovery from delayed graft function but does not affect 1-year graft function 186
Isolation and characterization of cancer stem cells in renal cell carcinoma. 186
Urinary RKIP/p-RKIP is a potential diagnostic and prognostic marker of clear cell renal cell carcinoma 182
A single-center cohort study to define the role of pretransplant biopsy score in the long-term outcome of kidney transplantation. 179
Clinical management of a unique case of PNET of the uterus during pregnancy, and review of the literature 172
Recurrent urinary tract infections in kidney transplant recipients during the first-year influence long-term graft function: a single-center retrospective cohort study 171
Androgen deprivation therapy affects BCL-2 expression in human prostate cancer 170
An increased body mass index is associated with a worse prognosis in patients administered BCG immunotherapy for T1 bladder cancer 169
Renal Cell Carcinoma: A Study through NMR-Based Metabolomics Combined with Transcriptomics 167
Bilateral tumors of the testis in 21-alpha hydroxylase deficiency without adrenal hyperplasia 165
Capillary hemangioma of the scrotum mimicking an epididymal tumor: case report. 165
Complement-dependent NADPH oxidase enzyme activation in renal ischemia/reperfusion injury. 164
Dysfunctional DC subsets in RCC patients: Ex vivo correction to yield an effective anti-cancer vaccine 163
Soluble Serum αklotho Is a Potential Predictive Marker of Disease Progression in Clear Cell Renal Cell Carcinoma 163
Pre-existing Type 2 Diabetes Mellitus Is an Independent Risk Factor for Mortality and Progression in Patients With Renal Cell Carcinoma. 160
Impact of donor-recipient gender on kidney graft and patient survival: short- and long-term outcomes. 159
Allograft nephrectomy: what is the best surgical technique? 159
BCG septicemia after radical cystectomy: a rare postoperative complication following BCG therapy 158
Experience of percutaneous access under ultrasound guidance in renal transplant patients with allograft lithiasis 157
Complement activation during ischemia/reperfusion injury induces pericyte-to-myofibroblast transdifferentiation regulating peritubular capillary Lumen Reduction Through pERK Signaling 157
A challenging surgical approach to locally advanced primary urethral carcinoma: A case report and literature review 156
Penile prosthesis implant: when, what and how 154
Adherence to EAU guidelines on penile cancer translates into better outcomes: a multicenter international study 154
Uridine and pyruvate protect T cells’ proliferative capacity from mitochondrial toxic antibiotics: a clinical pilot study 154
Interleukin-27 is a potential marker for the onset of post-transplant malignancies 153
Penile prosthesis implant for primary erectile dysfunction in patient with Klippel-Trenaunay syndrome complicated by consumptive coagulopathy: A case report 153
Rapamycin for treatment of chronic allograft nephropathy in renal transplant patients 151
Predictive value of resistive index in graft survival after kidney transplant. 151
Microvascular density, macrophages, and mast cells in human clear cell renal carcinoma with and without bevacizumab treatment 151
ANGIOMIOLIPOMA CALCIFICO DEL RENE. 145
T helper 1, 2 and 17 cell subsets in renal transplant patients with delayed graft function 145
Spondin-2, a Secreted Extracellular Matrix Protein, Is a Novel Diagnostic Biomarker for Prostate Cancer. 145
Allograft nephrectomy: Intracapsular vs extracapsular tecnique 144
Androgen deprivation therapy regulation of beta 1C integrin expression in prostate cancer 142
Endothelial-to-Mesenchymal Transition (EndMT) in Swine Renal Ischemia Reperfusion (I/R) Injury Is Mediated by Complement and AKT Pathway 141
Extended criteria donor kidney transplantation: comparative outcome analysis between single versus double kidney transplantation at 5 years 140
SERUM SARCOSINE INCREASES THE ACCURACY OF PROSTATE CANCER DETECTION IN LOW RANGE PSA 140
Role of imaging and biopsy to assess local recurrence after definitive treatment for prostate carcinoma 140
Prednisone plus gefitinib versus prednisone plus placebo in the treatment of hormone-refractory prostate cancer: a randomized phase II trial 139
Lymph node staging in early prostatic carcinoma with radioguided sentinel node biopsy 139
DelCFHR3-1 influences graft survival in transplant patients with IgA nephropathy via Complement-mediated cellular senescence 139
Cyclosporin exposure correlates with 1 year graft function and histological damage in renal transplanted patients 138
UROCITOLOGIA E COLPOCITOLOGIA IN CLIMATERIO E NELLA SENILITA' 137
Genome-wide analysis of differentially expressed genes and splicing isoforms in clear cell renal cell carcinoma. 137
Lethal somatostatin analog-induced acute necrotizing pancreatitis in a patient with hormone-refractory prostate cancer 136
Serum sarcosine is a risk factor for progression and survival in patients with metastatic castration-resistant prostate cancer. 136
Repair of vaginal prolapse following penoscrotal flap vaginoplasty in a male-to-female transsexual 134
Approccio laparoscopico alla patologia renale 134
Single-step surgical tretment of adrenal pheochromocytoma and medullary thyroid carcinoma in Sipple's Syndrome 134
Emerging urinary markers of renal injury in obstructive nephropathy. 133
Establishment and characterization of a highly immunogenic human renal carcinoma cell line 133
"Deviceless" hand-assisted laparoscopic donor nephrectomy 133
Diagnostic and prognostic role of preoperative circulating CA 15-3, CA 125, and beta-2 microglobulin in renal cell carcinoma. 133
ATTEMPT TO CORRECT IMMUNE DEFICITS IN PATIENTS WITH CHRONIC URINARY-TRACT INFECTION BY ADMINISTRATION OF A THYMIC EXTRACT 133
VHL gene alterations in Italian patients with isolated renal cell carcinomas 132
Advanced age is not an exclusion criterion for kidney transplantation. 132
Spontaneous rupture of an ileal neobladder 6 years after construction 131
Altered p53 and pRb expression is predictive of response to BCG treatment in T1G3 bladder cancer. Anticancer Res. 2009 Oct;29(10):4201-4. PubMed PMID: 19846973 129
Systemic Inflammatory Markers and Oncologic Outcomes in Patients with High-risk Non–muscle-invasive Urothelial Bladder Cancer 129
Adherence to the EAU guidelines on Penile Cancer Treatment: European, multicentre, retrospective study 127
A CLUSTER OF PROTEINS SECRETED BY HUMAN RENAL STEM/PROGENITOR CELLS (ARPCS) PROVIDE A NOVEL STRATEGY TO REVERT ENDOTHELIAL DYSFUNCTION AND RENAL INJURY IN SEPSIS-INDUCED ACUTE KIDNEY INJURY (AKI) 127
Penile prosthesis: what should we do about complications? 126
Evaluation of tamoxifen and anastrozole in the prevention of gynecomastia and breast pain induced by bicalutamide monotherapy of prostate cancer 126
Ischemia-reperfusion induces glomerular and tubular activation of proinflammatory and antiapoptotic pathways: differential modulation by rapamycin 126
Complement-Mediated Acute Induction of Endothelial-to-Mesenchymal Transition in a Swine Model of Renal Ischemia/Reperfusion (I/R) Injury 125
Interferon-alpha (IFN-alpha) –conditioned DC Preferentially Stimulate Type-1 and Limit Treg-type In Vitro T-cell Responses From RCC Patients 124
GOSERELIN ACETATE WITH OR WITHOUT FLUTAMIDE IN THE TREATMENT OF PATIENTS WITH LOCALLY ADVANCED OR METASTATIC PROSTATE-CANCER 123
Therapeutic targeting of classical and lectin pathways of complement protects from ischemia-reperfusion-induced renal damage 123
Optimization of analytical and pre-analytical conditions for MALDI-TOF-MS human urine protein profiles 123
Integration of lipidomics and transcriptomics reveals reprogramming of the lipid metabolism and composition in clear cell renal cell carcinoma 123
Pentraxin-3-mediated complement activation in a swine model of renal ischemia/reperfusion injury 123
Kidney transplants from infected donors: Our experience 122
Reperfusion blood pressure as risk, factor for delayed graft function in cadaveric kidney transplant 122
The emerging role of obesity, diet and lipid metabolism in prostate cancer 122
PTX3 modulates the immunoflogosis in tumor microenvironment and is a prognostic factor for patients with clear cell renal cell carcinoma 122
Influence of bicalutamide with or without tamoxifen or anastrozole on insulin-like growth factor 1 and binding proteins in prostate cancer patients 121
Adjuvant hormone therapy after radical prostatectomy: Indications and results 120
Incidental prostatic cancer: repeat TURP or biopsy? 120
Prospective randomized trial comparing high lumbotomic with laparotomic access in renal cell carcinoma surgery 120
null 119
The three-gene signature in urinary extracellular vesicles from patients with clear cell renal cell carcinoma 119
DIABETES MELLITUS IN RENAL CELL CARCINOMA: ROLE OF OGG1 AND TUBERIN 119
DIABETES MELLITUS IS A RISK FACTOR FOR RECURRENCE AND MORTALITY IN PATIENTS WITH RENAL CELL CARCINOMA . 119
How radical prostatectomy procedures have changed over the last 10 years in Italy: a comparative analysis based on more than 1500 patients participating in the MIRROR-SIU/LUNA and the Pros-IT CNR study 119
Current insights in renal cell cancer pathology 117
Totale 16.982
Salva come PNG Salva come JPEG
Categoria #
all - tutte 170.864
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 170.864
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.261 0 0 0 0 0 0 0 0 0 523 411 327
2021/20222.909 170 426 52 128 159 180 124 169 168 211 464 658
2022/20234.659 708 416 246 459 536 618 94 505 769 55 138 115
2023/20241.708 200 317 110 112 124 448 57 98 23 51 33 135
2024/20256.546 130 136 609 281 160 561 485 578 271 319 960 2.056
2025/202610.625 2.021 488 719 1.287 1.388 712 1.464 368 1.104 1.074 0 0
Totale 41.214